Full investment portfolio of the Relevant Investments as at 30 April 2022
Relevant Investment | Type | Primary Listing | Country of Issuer | Currency | Total Cost | Mark-to-market Value | Weighting of GAV *(%) | Credit Rating (S&P's/Moody's/Fitch's) |
NANFUN 4 ½ 09/20/22 EMTN | Bond | Singapore Exchange | BVI | USD | HK$9,797,000 | HK$9,436,000 | 0.0140% | BBB- / Baa3 / - |
NANFUN 4 ⅞ 05/29/24 EMTN | Bond | Singapore Exchange | BVI | USD | HK$56,602,000 | HK$54,122,000 | 0.0805% | BBB- / Baa3 / - |
HKTGHD 3 ¾ 03/08/23 | Bond | Singapore Exchange | BVI | USD | HK$49,641,000 | HK$49,641,000 | 0.0738% | BBB / Baa2 / - |
CAPG 6.35 02/08/24 | Bond | Singapore Exchange | Cayman Islands | USD | HK$38,747,000 | HK$8,924,000 | 0.0133% | - / - / C |
MOLAND 11 ½ 11/13/22 | Bond | Singapore Exchange | Cayman Islands | USD | HK$3,809,000 | HK$1,217,000 | 0.0018% | - / - / - |
CIFIHG 5.95 10/20/25 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$46,493,000 | HK$37,180,000 | 0.0553% | BB- / - / BB |
SHUION 5 ¾ 11/12/23 | Bond | Singapore Exchange | Cayman Islands | USD | HK$27,630,000 | HK$29,967,000 | 0.0446% | - / - / - |
HKE 2 7/8 05/03/26 | Bond | Hong Kong Exchange | BVI | USD | HK$7,758,000 | HK$7,590,000 | 0.0113% | A- / - / - |
EC Healthcare (Stock Code: 2138.HK) | Equity | Hong Kong Exchange | Cayman Islands | HKD | HK$51,810,000 | HK$98,619,000 | 0.1467% | N/A |
AIA (Stock Code: 1299.HK) | Equity | Hong Kong Exchange | Hong Kong | HKD | HK$11,413,000 | HK$11,274,000 | 0.0168% | N/A |
CCB (Stock Code: 939.HK) | Equity | Hong Kong Exchange | People’s Republic of China | HKD | HK$11,468,000 | HK$11,460,000 | 0.0170% | N/A |
ICBC (Stock Code: 1398.HK) | Equity | Hong Kong Exchange | People’s Republic of China | HKD | HK$11,831,000 | HK$12,324,000 | 0.0183% | N/A |
HKEX (Stock Code: 388.HK) | Equity | Hong Kong Exchange | Hong Kong | HKD | HK$11,390,000 | HK$10,471,000 | 0.0156% | N/A |
HSBC Holdings (Stock Code: 5.HK) | Equity | Hong Kong Exchange | England | HKD | HK$11,696,000 | HK$11,167,000 | 0.0166% | N/A |
Total | HK$350,086,000 | HK$353,391,000 | 0.5256% |